Aborted myocardial infarction after primary percutaneous coronary intervention: Magnetic resonance imaging insights from the assessment of pexelizumab in acute myocardial infarction (APEX-AMI) trial

American Heart Journal

Volumn 165, Issue 2, 2013, Pages 226-233

  Patel, Manesh R ^a   Westerhout, Cynthia M ^b   Granger, Christopher B ^a   Brener, Sorin J ^c   Fu, Yuling ^b   Siha, Hany ^b   Kim, Raymond J ^a   Armstrong, Paul W ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB;

ABORTED MYOCARDIAL INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL, HUMANIZED; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; SINGLE-CHAIN ANTIBODIES; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84872866627     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.10.028     Document Type: Article

References (25)

1. W.D. Weaver, M. Cerqueira, and A.P. Hallstrom Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial JAMA 270 1993 1211 1216
2. T. Taher, Y. Fu, and G.S. Wagner Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy J Am Coll Cardiol 44 2004 38 43
3. F.W. Verheugt, B. Gersh, and P.W. Armstrong Aborted myocardial infarction: a new target for reperfusion therapy Eur Heart J 27 2006 901 904
4. The APEX-AMI Investigators Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial JAMA 289 2007 43 51
5. M.R. Patel, S.G. Worthley, and A. Stebbins Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary PCI: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial J Am Coll Cardiol Imag 3 2010 52 60
6. O.P. Simonetti, R.J. Kim, and D.S. Fieno An improved MR imaging technique for the visualization of myocardial infarction Radiology 218 2001 215 223
7. A. Wagner, H. Mahrholdt, and L. Thomson Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement J Am Coll Cardiol 47 2006 2027 2033
8. K.W. Mahaffey, C.J. Reist, and Y. Fu Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library Contemp Clin Trials 29 6 2008 887 895
9. TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings N Engl J Med 312 1985 932 936
10. C.M. Gibson, C.P. Cannon, and S.A. Murphy Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation 105 2002 1909 1913
11. A. Poli, R. Fetiveau, and P. Vandoni Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function Circulation 106 2002 313 318
12. A. Stebbins, R.H. Mehta, and P.W. Armstrong A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Circ Cardiovasc Interv 3 2010 414 422
13. M. Francone, C. Bucciarelli-Ducci, and I. Carbone Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 2145 2153
14. J.T. Ortiz-Perez, A. Betriu, and D.C. Lee Angiographic and magnetic resonance imaging evaluation of in-hospital delay in primary percutaneous intervention delivery on myocardial salvage Am J Cardiol 106 2010 924 930
15. I. Eitel, S. Desch, and M. Sareban Prognostic significance and magnetic resonance imaging findings in aborted myocardial infarction after primary angioplasty Am Heart J 158 2009 806 813
16. K.A. Reimer, J.E. Lowe, and M.M. Rasmussen The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs Circulation 56 1977 786 794
17. K.A. Reimer, and R.B. Jennings The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow Lab Invest 40 1979 633 644
18. E.J. Lamfers, T.E. Hooghoudt, and A. Uppelschoten Effect of prehospital thrombolysis on aborting acute myocardial infarction Am J Cardiol 84 1999 928 930
19. K. Huber, R. De Caterina, and S.D. Kristensen Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction Eur Heart J 26 2005 2063 2074
20. D.P. O'Regan, R. Ahmed, and C. Neuwirth Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention Am J Physiol Heart Circ 297 2009 H340 H346
21. I. Eitel, S. Desch, and G. Fuernau Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction J Am Coll Cardiol 55 2010 2470 2479
22. A.G. Bertaso, J.D. Richardson, and D.T. Wong Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population Int J Cardiol 2012 [epub ahead of print]
23. I. Klem, D.J. Shah, and R.D. White Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study Circ Cardiovasc Imaging 4 2011 610 619
24. I. Klem, J.W. Weinsaft, and T.D. Bahnson Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation J Am Coll Cardiol 60 2012 408 420
25. Y. Fu, S. Goodman, and W.C. Chang Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial Circulation 104 2001 2653 2659